Research assistant
Anne Mette Kristensen
Research unit of screening and epidemiology, Department of Biochemistry and Immunology, Lillebaelt Hospital
| Projekt styring | ||
| Projekt status | Open | |
| Data indsamlingsdatoer | ||
| Start | 30.11.2025 | |
| Slut | 30.11.2029 | |
In 3 out of 4 women with a positive screening for breast cancer, subsequent tests show that they do not have cancer. We will investigate whether a blood test can be used to find women without breast cancer. This will allow these women to be spared from tests that many find unpleasant and psychologically stressful. This will also free up time and resources in the health care system.
Breast cancer screening is offered to all Danish women aged 50-69. Around 2.5% are recalled after suspicious findings, but only one in four actually have cancer. The rest experience discomfort, anxiety and unnecessary tests. In Norway, fewer interval cancers are seen at a higher recall rate, but this increases the pressure on the healthcare system. A blood-based test can be a gentle and resource-saving supplement that targets efforts to those in greatest need. Project question Can blood-based biomarkers identify women at low risk of breast cancer among those recalled after screening, thereby reducing the need for unnecessary tests - without compromising the ability to find cancer cases early? This will free up more resources for high-risk patients.
Women who are recalled to supplementary examination at Vejle or Odense Hospital after initial mammography screening
blood, samples, data from patients medical journals, possibly mammography images
Røntgen og Scanning, Lillebaelt hospital
Blodprøver og biokemi, Odense Universitetshospital
Radiologisk afdeling, Odense universitetshospital